Refine by
Diagnostic Assay Suppliers & Manufacturers
62 companies found
based inEllesmere Port, UNITED KINGDOM
For over 10 years BIOHIT Healthcare has supplied diagnostic tests, health products and services to improve the care of digestive diseases and ease patient management, both in the UK and worldwide. We manufacture and supply diagnostic tests that are ...
SmarTest® faecal calprotectin home test is a simple-to-use inflammatory bowel disease stool test that enables individuals with Crohn’s disease or Ulcerative colitis to monitor their disease activity at home. Patients can use the ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 ...
based inWindsor, NOVA SCOTIA (CANADA)
BioMedica Diagnostics is a specialized company offering diagnostic solutions with a strong focus on Thrombosis and Haemostasis. The company collaborates globally with technology development firms and healthcare stakeholders to engineer and ...
ACTICHROME Heparin (Anti-FIIa) is an in vitro diagnostic three-stage assay. It begins with plasmas containing heparin interacting with human antithrombin III to form a heparin-ATIII complex. In the second stage, ...
based inFairfield, NEW JERSEY (USA)
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. From scientists striving to make research advances to technicians reporting the ...
The Sentosa ST401 System is an automation solution for sequencing template preparation and template enrichment, steps that immediately precede sample sequencing. The system consists of two instrument components, the Sentosa ST401i and Sentosa ...
based inDavis, CALIFORNIA (USA)
Gold Standard Diagnostics provides comprehensive diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and outstanding customer service, we solve real ...
Respiratory diseases caused by SARS-CoV-2, RSV, and Influenza virus have similar first clinical symptoms, and accurate identification is crucial for better patient care. Gold Standard Diagnostics’ new multiplex ...
based inShirley, NEW YORK (USA)
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers ...
based inCoralville, IOWA (USA)
A champion of life sciences research for more than 30 years, IDT develops and manufactures nucleic acid products that support the life sciences industry. Areas of focus include academic and commercial research, agriculture, medical diagnostics, ...
We have combined our proven oligo manufacturing expertise and ISO 13485 certified production processes to deliver GMP-manufactured MGB Eclipse Probes and companion primers. Together, these probe and primer pairs are ideal for genotyping qPCR assays. ...
based inBeijing, CHINA
Chemclin Diagnostics Co., Ltd (hereinafter it was referred to as Chemclin Diagnostics), founded in 2007, is one of the pioneers in developing clinical immunoassays and systems in China. Chemclin Diagnostics is specialized in the research and ...
based inRedondo Beach, CALIFORNIA (USA)
Quantimetrix designs, develops, and manufactures laboratory quality products at our headquarters in Redondo Beach, California. We are leaders in the field of liquid-stable quality control products, having pioneered these innovations more than 40 ...
based inIrving, TEXAS (USA)
Avero Diagnostics is dedicated to making a positive impact on the lives of patients and the physicians who treat them. We bring a patient-centered approach to every aspect of our organization, including our laboratory and research facility. It’s ...
based inSunnyvale, CALIFORNIA (USA)
We are developing cellular and cell-derived therapeutics for the treatment of unmet cardiovascular and pulmonary diseases. Our Mission: To improve the lives of patients with cardiovascular and pulmonary diseases through the development of ...
The investigational CardiAMP™ Cell Therapy is designed to be a comprehensive biotherapeutic heart failure solution, incorporating: a proprietary molecular diagnostic to characterize the potency of a patient’s own bone marrow cells and ...
based inLund, SWEDEN
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly ...
ESR1 mutations are found in primary breast cancers prior to therapy initiation and are associated to worse relapse-free and overall survival. These results were reported today by a group of researchers from Lund University and Skåne University ...
based inBrignais, FRANCE
Appolon Bioteck is a French research-focused healthcare company with combined strengths in Medical genetic diagnostics, oncology, virology and inflammation. We provide diagnostic tools that enable tangible improvements in the health, quality of life ...
Companion diagnostics is becoming a key element in cancer treatment. New predictive biomarkers and molecular strategies for personalized cancer therapies are currently available to treat each individual patient depending on the ...
based inNeuchâtel, SWITZERLAND
1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic ...
based inUdine, ITALY
Ulisse BioMed is an Italian healthcare biotech company with corporate offices in Udine, Italy and with R&D and Manufacturing labs in Trieste, Italy. Ulisse BioMed is creating novel, innovative and transformative diagnostic platforms and products. ...
The assay is intended for the qualitative detection of RNA from SARS-CoV-2 in clinician-collected nasopharyngeal swab specimens from patients with signs and symptoms suggestive of COVID-19 (e.g., fever and/or symptoms of acute respiratory ...
based inMadison, WISCONSIN (USA)
BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company, we identify areas where there is a strong need but a ...
based inMarlborough, MASSACHUSETTS (USA)
Cytiva, now with the life sciences business from Pall, is a global provider of technologies, services, and expertise to help researchers and companies protect and preserve the planet for improved human health and safety. Our products offer quality, ...
based inOxford, UNITED KINGDOM
The Native Antigen Company has developed a proprietary HEK293 mammalian expression system (VirtuE) for expression of recombinant proteins. The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease ...
based inBeaverton, OREGON (USA)
Sedia Biosciences is a privately held Delaware-registered medical device and diagnostics company founded in 2009 and based in Beaverton, Oregon, USA. Our commitment is to become a leader in three areas intended to advance global access to care: ...